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Abstract. Altered T cell adherence after human im-
munodeficiency virus 1 (HIV1) infection may contrib-
ute to viral pathogenesis in the acquired immune
deficiency syndrome. To address this hypothesis, we
assessed mechanisms of T cell adherence to extracel-
lular matrix proteins in vitro. We found that after
HIV-1 infection, both chronically infected H9 CD4+
T cells and acutely infected primary peripheral blood
lymphocytes acquired the ability to adhere to the ex-
tracellular matrix glycoprotein fibronectin, to a lesser
extent to type IV collagen and laminin, but not to
type I collagen. H9 cells chronically infected with two
of the three HIV-1 strains studied showed approxi-
mately a sevenfold increase in attachment to fibronec-
tin, while the same cells infected with the human
retrovirus HIV-2 did not. Adhesion was accompanied
by changes in morphology, including marked spread-
ing and increased filopodia. These alterations were not
blocked by the protein kinase C inhibitor H-7, which
did inhibit TPA-induced T cell attachment to
NFECTION with HIV-1 is associated with a progressive
reduction in the number ofcirculating CD4+ T cells (8,
41). The resultant clinical syndrome is dominated by the
sequelae of immunodeficiency, AIDS. Recent evidence,
however, suggests that a number of the protean manifesta-
tions of HIV-1 infection including Kaposi's sarcoma (6),
AIDS-associated dementia (23), and HIV-associated ne-
phropathy (Adler, S. A., J. B. Kopp, P Dickie, N. J. Mar-
inos, J. L. Bryant, J. M Felser, A . L. Notkins, and P E. Klot-
man. 1990. J. Am. Soc. Nephrol. 1:513a) may result from
complex interactions between infected T cells, viral gene
products, and host tissues.
One potential mechanism for T cell targeting is through
an interaction with extracellular matrix proteins including
fibronectin, collagen IV, laminin, entactin, and heparan sul-
fate proteoglycan . (2, 12, 18, 26, 33, 34, 46). Lymphocytes
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fibronectin . Monoclonal antibodies against both the a5
and the (31 subunits of the classical fibronectin receptor
as well as an Arg-Gly-Asp (RGD) peptide inhibited at-
tachment, whereas anti-a4 monoclonal antibodies and
the CS1 peptide did not. Binding to collagen IV was
also inhibited by the anti-al monoclonal antibody, but
not the other antibodies. Cells metabolically labeled
with [35S]methionine and analyzed by immunoprecipi-
tation with polyclonal anti-/31 integrin antibody
showed a 2.5-fold increase in integrin synthesis in in-
fected cells compared to uninfected controls. This in-
crease in synthesis was associated with an increase in
cell surface expression of both as and 01 integrins by
FAGS® (registered trademark of Becton Dickinson for
a fluorescence-activated cell sorter) analysis. Enhanced
expression of integrins such as ao, may cause T cell
adherence to a variety of tissues, where released viral
gene products may induce some of the tissue-specific
manifestations of HIV-1 infection.
must attach to and then traverse basement membranes and
connective tissues to arrive at target tissues. Lymphocytes
possess cell surface receptors for the extracellular matrix
proteins known as integrins which recognize fibronectin,
fibrinogen, vitronectin, and laminin. (1, 14-16, 20, 27, 28,
51, 53, 54, 60, 61). This family of receptors appears to play
an important role in tissue targeting, activation, and cell rec-
ognition by lymphocytes. In the present study, we have ad-
dressed potential mechanisms of T cell targeting by examin-
ing whether HIV-1 infection alters the interaction of T cells
with extracellular matrix molecules (for review see refer-
ence 53) .
Materials andMethods
Cell Lines
H9 cells (39) and H9 cells chronically infected with the HIV -1 strains HIB
847(HIV11111) (39), MN (HIVIMN) (48), and RF (HIV1RF) (48) as well as the
HIV-2 strain NIH Z (HIV2NIH z) (62) were used in the initial studies.
Infection ofHuman Peripheral Blood
Lymphocytes(PBL)
PBL were obtained from three single donor packs from normal blood
donors. T cells were isolated by Ficoll gradient centrifugation, stimulated
with 5 pg/ml phytohernagglutinin (PHA) for 48 h in RPMI supplemented
with 10% FCS, followedby removal of adherent cells. Stimulatedcells were
subsequently cultured in RPMI supplemented with 10% FCS and 10% hu-
man IL2 (Advanced Biotechnologies, Inc., Columbia, MD). After stimula-
tion for 48 h, 2 x 101 cells in 5 ml were treated with polybrene (5 wg/ml),
and HIV-1utB was added to the medium at 0.1 and 1.0 infectious virus parti-
cles/cell. After 2 h of virus adsorption, the volume was expanded to 20 ml
with medium. After 24 h, cells were washed free of virus, and cell attach-
ment to fibronectin was determined at 1, 2, and 5 d after infection. Infection
of cells was confirmed by reverse transcriptase activity and the presence of
the core protein, P24, by immunofluorescence microscopy.
CellAttachmentAssays
Cell attachment was determined by a modification of a previously described
method (21) . Tissue culture plates (Costar, Cambridge, MA) were coated
with one of the following substrates: bovine serum albumin (Boehringer
Mannheim Biochemicals, Indianapolis, IN), collagen I (Sigma Chemical
Co., St. Louis, MO), laminin (58), collagen IV (22), or fibronectin (31).
Plates were coated by adding 10 ug of each substrate dissolved in 200 Al
water to 16-mm-diam wells in 24-well cell culture plates and air dried over-
night at 4°C.
Cells were harvested and washed three times in Dulbeccds phosphate
buffered saline, pH 7.4 (PBS) and resuspended in RPMI containing 100
pglml of transferrin, 100 pM putrescine, 20 nM progesterone, 30 nM
NaSe03, and 5 mg/ml of insulin. Cells were seeded in the coated plates at
a density of 0.4-0.5 x 106 cells/0.5 ml serum-free medium/well. Cells
were incubated for 5 h at 37°C. Unattached cells were then removed by
washing thewellstwice with 0.5 nil PBS. The attached cells werefixed with
methanol and stained with DiffQuick (Baxter Scientific Products, McGraw
Park, IL). Three 1.5-mm' fields per well were counted by observers
blinded to the experimental groups and the numbers of attached cells were
expressed as the mean t SEM of three fields in each of six wells.
The effect ofnonspecific T cell activation on adherence was assessed by
preincubation of H9 cells with 10 pg/ml Con A (Sigma Chemical Co.) or
10 Kg/ml PHA (Sigma Chemical Co.) for 6 h before plating. Cells were
washed and plated in coated wells in serum-free medium. Previous studies
suggest that activation with 12-O-tetradecanoylphorbol-13-acetate (TPA;
Sigma Chemical Co.) induces adhesion by protein kinase C activation. To
evaluate the role of protein kinase C in virus-induced adhesion, H9 cells
chronically infected with HIV1IIIB were plated in coated wells containing
serum-free medium alone or medium supplemented with 90 AM H-7, apro-
tein kinase C inhibitor (Seikagaku America Inc., Rockville, MD). As an
additional control, the role of protein kinase C in T cell adhesion induced
by nonspecific mitogen was also explored. Uninfected H9 cells were plated
in medium alone, medium supplemented with 100 nM TPA or medium sup-
plemented with both TPA and 90 AM H7.
To determine the specific cell-surface receptors for fibronectin, inhibi-
tionassays were performed using peptides or receptor subunit-specific anti-
bodies. HIV-1-infected cells (5 x 103) were cultured on increasing amounts
of fibronectin with the addition of 150 Kg of peptide at the time of plating.
These peptides contained the amino acidsequences RGD (GRG D S), RGE
(GR G E S), or DELPQLVTLPHPNLHGPEILDVPST, the CSl (connect-
ing segment) peptide from an alternatively spliced region offibronectin (9).
After 5 h, the numbers of attached cells were determined as above.
In additional experiments, HIV-1-infected H-9 cells were plated on
fibronectin in the presence of0.5 mg/ml control IgG (rat) or 0.5 mg/ml of
the monoclonal antibodies to the 0, (mAb 13), a4 (8F2), or a3 (mAb 16)
integrin subunits. The a4 antibody was generated in ascites fluid (36) and
the control for this antibody was an equal volume of nonimmune ascites
fluid (BethesdaResearch Laboratories, Bethesda, MD). After 5 h, the num-
ber of attached cells was determined.
Immunoprecipitation ofIntegrin Subunits
Chronically infected and uninfected H9 cells (30 x 106 were cultured in
5 ml methionine-free RPMI containing 10% FCS and 2 .0 mCi ["Slmethi-
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onine for 24 h. After labeling, cells were washed four times in a total of
200 ml RPMI. The sedimented pellet was resuspended in 1.5 ml 2 % Tri-
ton-X 100 containing 0.2 mM PMSF The samples were briefly sonicated
and pre-absorbed with protein A-Sepharose (Sigma Chemical Co.). The
protein content ofthe cell lysate was determined by the Bradford assay (Bio-
Rad Laboratories, Richmond, CA). An equal quantity of protein (5 mg)
from both H9 and HIV-1-infected cell homogenates was diluted in a volume
of 1.0 ml ofPBS. The H9 lysate contained 286,624 TCA-precipitablecpm/;A1
and the HIV-1-infected lysate contained 231,856 TCA-precipitable cpm/pl .
Lysates
anti-01
precipitated at 4°C with a 1:200 dilutionof either nonimmune
or anti-FN1 polyclonal antiserum (Rb 3847) (43). Samples were analyzed by
electrophoresis on a 5 % polyacrylamide gel, which was then dried and ex-
posed to x-ray film. Bands on the autoradiogram were quantitated by laser
densitometry (Shimadzu scanner; Shimadzu, Tokyo, Japan), lane back-
ground was subtracted, and the density was expressed as a ratio of infected
to control cells.
Fluorescence Activated CellAnalysis (FRCS)
Cell surface expression of 01 integrin on HIV-1-infected and uninfected
H-9 cells was determined by FACS analysis. 100,000 cells were incubated
in 100 gl RPMI 1640 containing 5 1A of nonimmune serum (control) or
5 WI of anti-R1 polyclonal antiserum for 1 h at 37°C. Cells were washed
seven times with 1 ml 0.05% Tween-20 in PBS, resuspended, and incubated
with a 1:50 dilution of the appropriate FITC-conjugated antibody at 37°C
for 1 h. Cells were then washed seven times, fixed in 2 % paraformaldehyde
overnight, and analyzed by FACS. To determine the cell surface expression
of the as integrin subunit, cells were analyzed essentially as above but
10014g ofanti-«3 monoclonal antibody were used for cell surface labeling
and 100 Ag rat IgG were used as control.
Results
Morphology andAdhesive Properties ofInfected Cells
Cultured On Fibronectin
H9 cells, grown in suspension and chronically infected with
HIV1111,,, exhibited striking morphological changes charac-
terizedby marked spreading and by the productionof numer-
ous filopodial projections in the presence of fibronectin sub-
strate (Fig. 1) . These changes were associated with increased
attachment to fibronectin, collagen IV, and laminin (Fig. 2
A) ; attachment was greatest to fibronectin and least to lami-
nin. No enhanced attachment was observed to interstitial
collagen type I . The specificity of the enhanced attachment
of HIV-1-infected lymphocytes to extracellular matrix pro-
teins was tested using a number of viral strains. H9 lympho-
cytes chronically infected with HIV-1,,,, also showed a
sevenfold increase in attachment to fibronectin. H9 cells
chronically infected with HIV1 RF or HIV2NIH z failed to
show enhanced attachment (data not shown). Attachment of
HIV-1-infected cells occurred within 1 h of plating onto the
substrate and was maximal after 3-5 h.
Qualitatively identical results were observed when human
PBL were acutely infected with HIV1BIB (Fig. 2 B), al-
though the magnitude of the response was blunted by the na-
ture ofthe mixed T cell population. Similar to the results ob-
served for H9 cells, acute HIV11118 infection stimulated a
significant increase in attachment of PBL to fibronectin
which was maximally observed 2 d after infection.
Since T cell activation alone can induce attachmentto sev-
eral extracellular matrix components, we compared the at-
tachment of H9 cells to fibronectin when activated either by
nonspecific mitogens or by HIV11118 infection. Neither Con
A nor PHA stimulated increased attachment of uninfected
cells to fibronectin (Table I). Treatment with TPA, however,
significantly increased uninfected H9 cell attachment to
848Figure 1. Morphology of CD4+ T lymphocytes plated on fibronectin . Uninfected and HIV1um-infected H9 cells were plated (5 x 105)
in glass 1 cmz multi-chamber slides which had been coated with 10 FAg of human plasma fibronectin . After 5 h, cells were washed with
RPMI and fixed in methanol, stained with hematoxylin and eosin, and viewed by light microscopy (top), or fixed in 2.5% glutaraldehyde
and viewed by scanning electron microscopy (bottom) .
fibronectin by fivefold within 1 h of plating . TPA treatment
of infected cells further enhanced attachment to fibronectin
(-twofold) . The increase in attachment of uninfected H9
cells in response to TPA could be blocked almost completely
by the protein kinase C inhibitor H-7. In contrast, addition
of H-7 to HIV-1-infected cells had no significant effect (Ta-
ble I) . These data suggest that TPA-induced attachment oc-
curs by a mechanism different from that of HIV-1-induced
attachment .
Identification ofCell Surface Receptors Responsible
forEnhancedAttachmentofInfected Cells
To identify the fibronectin receptor used by HIV1, t. in-
fected cells, monoclonal antibodies specific for integrin
subunits were tested for their ability to block attachment to
fibronectin . Monoclonal antibodies to both the /3, and the
as subunits of the classical fibronectin receptor significantly
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inhibited attachment (Fig . 3 A) while an antibody to another
fibronectin receptor subunit a, did not . The combination of
anti-a, and anti-as antibodies was not additive and, thus,
did not reveal a subtle effect of the a, subunit . Because
HIV-1-infected cells also attached to collagen IV, although to
a much lesser extent, antibodies to the collagen-binding 0,
integrins were tested for their ability to inhibit attachment
to collagen IV. The anti-a, antibody inhibited cell attach-
ment to collagen IV but, as expected, anti-as and anti-a,
antibodies (which are not collagen IV receptors) had no
effect (data not shown) . Because the a5 integrin of T lym-
phocytes recognizes a domain containing the RGD amino
acid sequence in fibronectin and a, recognizes the CSI al-
ternatively spliced region of fibronectin (2, 12, 14, 17, 20,
27, 28, 34, 36, 46, 51, 54, 61) peptides containing these se-
quences were tested for their ability to inhibit the attachment
of HIV-1-infectedH9 cells to fibronectin . Consistent with the
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Figure 2. HIV-1-induced T lymphocyte attachment to substrates. (A)
Chronically infected CD4+ T lymphocytes (H9) cultured on vari-
ous substrates in 48-well culture dishes (11.3 mmz wells) coated
with 10 hg of: bovine serum albumin (BSA); collagen I (Col I);
laminin (LN); collagen IV (Col IV); or fibronectin (FN). (B)
Acutely infected peripheral blood lymphocytes cultured on fibro-
nectin. HIV1111$ was added to the medium at a multiplicity of in-
fection (MOI) of0.1 or 1.0 and cell attachment to fibronectin was
determined 1, 2, and 5 d afterinfection. At all times, HIV1-infected
PBL attachment was significantly greater than that observed in
uninfected cells. Each bar represents the mean t SEM for results
from PBL using three individual donors.
Table 1. E ffect of T Cell Activation on Attachment to
Fibronectin by HIV-1-infected and Uninfected Cells
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Before plating, cells were preincubated for 6 hwith 10 wg/ml ConAor 10 Wg/
ml phytohemagglutinin (PHA). These cells and unstimulated cells were washed
and plated in control medium or medium containing 100 nM TPA, or 90 ,UM
H-7, a protein kinase C inhibitor. Cells were cultured on either bovine serum
albumin or fibronectin as described in Materials and Methods.
* <0.05 vs. control.
§ <0.005 vs. control.
f <0.025 vs. TPA.
II <0.005 vs. HIV-111,B.
antibody studies, the RGD-containing peptide but not the CS1
peptide inhibited attachmentto fibronectin (Fig. 3 B) . HIV-1-
induced attachment of PBL to fibronectin was inhibited by
the anti-ß, antibody and RGD peptide as well (data not
shown) .
Since increased attachment to fibronectin by HIV-1-
infected cells did not appear to involve phosphorylation
(TPA data, Table I), we examined whether HIV-1 induced an
increase in ß, integrin synthesis. As demonstrated by im-
munoprecipitation (Fig. 4), HIV-1 infection stimulated a 2.5-
fold increase in ß, integrin synthesis by H9 cells when
compared to uninfected controls. To determine whether this
increase in synthesis was associated with an increase in cell
surface expression, infected and uninfected H9 cells were
analyzed by FACS. HIV-1 infection induced an increase in
both ß, (Fig. 5 A) and «5 integrin (Fig. 5 B) subunits on the
cell surface of chronically infected H9 (HIVltna) cellswhen
compared to uninfected controls.
Discussion
Several tissue-specific manifestations of HIV-1 infection do
not appear to be related to immunodeficiency directly. For
example, the development ofKaposi's sarcoma (47) and HIV
associated nephropathy can occur before the development of
overt immunodeficiency (37). It is possible thatthese entities
involvea more direct role ofthe virus and/or viralgene prod-
ucts released from localized T cells. The present study ad-
dresses mechanisms involving the initial step of the local-
ization process, the attachment of HIV1-infected T cells
to extracellular matrix molecules. We have found that T
cellsthat normally grow in suspensionbecome markedly ad-
herent to fibronectin but not collagen I when chronically
infected with the HIV1® or the HIVIMN strains of HIV1.
Acute infection of either the H9 cell line or human PBL with
HIV-l  , produced a qualitatively identical result suggesting
that this was not simply a property of clonal selection of a
chronically infected cell line. The response was strain spe-
cific and HIV-2, which may be less pathogenic (25), did not
stimulate a similar degree of adherence. T cell adhesion in-
duced a marked change in morphology with cell spreading
and an increase in the number and length of filopodia. T cell
attachment to fibronectin did not appear to share a common
mechanism with the protein kinase C-mediated attachment
induced by the co-mitogen TPA; T cell attachment induced
by HIV-1 was not inhibited by a protein kinase C inhibitor
H7 whereas TPA-induced attachmentwas almost completely
blocked by H7. HIV-1-infected T cell attachmentto fibronec-
tin was mediated by the txsß, member of the integrin family
of cell surface receptors which recognizes the Arg-Gly-Asp
(RGD) amino acid sequence in fibronectin. HIV-1 infection
stimulated a 2.5-fold increase in ß, integrin synthesis as de-
termined by radioimmunoprecipitation and was associated
with an increase in cell surface expressionof both U5 and ß,
integrins by FACS analysis.
Lymphocytes are known to adhere to other cells as well
as to extracellular matrix proteins using cell-surface adhe-
sion molecules. For example, the lymphocyte function-
related antigens (LFAs) and the very late antigens (VLA-1 to
VLA-6) have been found to be members ofthe integrin gene
family of adhesion receptors (for reviews see references 50,
53, 55). Regulation of the receptors has been shown to in-
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Figure 3 Inhibition of HIV-1-in-
fectedH9 cell attachment to fibro-
nectin . (A) Inhibition of attach-
ment to fibronectin by antibodies
generated to the integrin subunits .
HIV-1-infected H-9 cells were cul-
tured on fibronectin as described
previously in the presence of 0.5
mg/ml control IgG (rat), or 0.5
mg/ml of the monoclonal antibod-
ies to the ,3, (mAb 13), as (8F2),
or as (mAb 16) integrin subunits.
(B) Inhibition of HIV-1-infected
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volve at least two possible mechanisms . First, phorbol ester
activation of protein kinaseC leads to neutrophil and macro-
phage adhesion to laminin (4, 30) . Macrophage treatment
with phorbol ester stimulates c«o, integrin phosphoryla-
tion, which suggests that posttranslational events can influ-
ence integrin activity (49) . Second, antigen stimulation of
lymphocytes or lymphocyte activation by cytokines can result
in increased synthesis and cell surface expression ofadhesive
molecules (5, 13, 57) . Our results indicate that HIV-1-in-
duced lymphocyte adhesion results from increased synthesis
of integrin and is probably not associated with a protein ki-
nase C-dependent pathway involving integrin phosphory-
lation .
Integrins facilitate a variety of lymphocyte functions in-
cluding infiltration, recirculation, and tissue-specific target-
ing and homing (for reviews see references 50, 53, 55) . To
achieve these tasks, circulating lymphocytes must attach to
Figure 4. Effects of HIV-1 in-
fection on integrin synthesis.
Immunoprecipitation of inte-
grin subunits in uninfected
and HIV-1-infected H9 cells.
Polyclonal rabbit antiserum to
R, integrin was used to evalu-
ate changes in ['5S]methio-
nine incorporation . Molecu-
lar mass standards, expressed
in kilodaltons, are also indi-
cated .
the vascular endothelium, then attach to and traverse the ex-
tracellular matrix, and ultimately bind to cells in lymph
nodes and tissue . The lymphocyte LFA-1 and VLA-4 inte-
grins bind to the endothelial cell adhesion molecules ICAM-1
and VCAM-1, respectively (for review see reference 53) and
are induced on lymphocytes and endothelium at sites of
inflammation in vivo (11, 35) . Furthermore, lymphocytes
can be targeted to specific tissues through specialized inter-
actions of lymphocyte integrins and endothelial adhesion
molecules . For example, the process by which circulating T
cells migrate to target tissues, as in the localization of lym-
phocytes to Peyer's patch in the gut, is mediated, in part, by
the interaction of COP on lymphocytes with the high en-
dothelial venules (15, 16) . The a4,8P integrin is distinct from
Mel/LAMI, which targets lymphocytes to peripheral lymph
Figure 5. (A) Cell surface expres-
sion of R, integrin on HIV-1-in-
fected and uninfected H-9 cells by
FACS analysis . Uninfected H-9
cell fluorescence intensity is in-
dicated in the unshaded area and
infected cell fluorescence is shown
by the shaded area . The (3, sub-
unit fluorescence intensity of
HIV-1-infected cells was 132%
greater than that of uninfected
cells . (B) Cell surface expression
of as integrin subunit on HIV-1-
infected and uninfected H-9 cells .
These studies were performed
identically to those in B, but 100
hg rat IgG was used as a control
and 100 Fig of anti-a5 monoclo-
nal antibody was used as the pri-
mary specific antibody. The as
subunit fluorescence intensity of
HIV-1-infected cells was 79% greater than that ofuninfected cells.
Increased intensity offluorescence was calculated by the following
formula: % increase in intensity = log- ' (number of channels/64)
x (100) where the number of channels is equal to the number of
channels shifted in the mean fluorescence intensity by HIV-1-infec-
tion . The shift in mean 0, = 25 channels and the shift in mean a5
= 12 channels. These experiments were performed in duplicate.
n LP- T - H9 cell attachment to fibronectin
851nodes (24, 55, 56) . Recently an endothelial leukocyte cell
adhesion molecule (ELAM) has been shown to serve as a
specific target for skin-homing memory T cells (38, 52). Fi-
nally, the ability of lymphocytes to interact with and traverse
the extracellular matrix is facilitated by the (3, integrin
group, also known as the lymphocyte VLA molecules (for
review see references 2, 3, 14, 29, 45) . These molecules are
induced in activated and memory T cells and have binding
specificities for the extracellular matrix proteins laminin,
collagens, and fibronectin .
The mechanism of cellular attachment to fibronectin and
other adhesion proteins appears to be highly conserved and
one that may serve as a relatively common pathway in patho-
genesis. For example, several microbial pathogens are inter-
nalized by phagocytic and nonphagocytic tissues by interac-
tions of integrins with their ligands, commonly but not
exclusively associated with the Arg-GlyAsp (RGD) tripep-
tide sequence (for review see references 19, 32, 40, 42) .
These previous observations in combination with those in
the present study suggest the possibility that the pathogene-
sis of HIV-1-related syndromes such as Kaposi's sarcoma,
AIDS-associated dementia, and AIDS-associated nephropa-
thy may also result from the exploitation of normal T cell ad-
herence properties. Our results suggest that HIV-1-infected
T cells may take advantage of an initial step in this process,
T cell attachment to extracellular matrix components, via
integrin adhesive systems. Thus, increased adhesion to
fibronectin and collagen IV which are found in endothelial
cell basement membranes or connective tissues could facili-
tate infected T cell entry and localization. Once localized in
tissues, the infected lymphocytes could infect local cells
and/or release viral gene products. In this regard, the viral
gene product, Tat, has recently been shown to undergo up-
take by cells and to affect cell behavior and gene expression
(6, 7, 10, 44). SinceVLA integrins play a critical role in lym-
phocyte localization in tissues, our finding that HIV-1 in-
duces the RGD-dependent integrin a50t (VLA-5) on in-
fected T cells provides a mechanism whereby HIV-1 and/or
secreted HIV-1 gene products couldbe localized to organtis-
sues. Such localization of infected T cells to target tissues
such as the skin, brain, or kidney, as well as the host re-
sponse to virus or viralgene products, couldhelp explain the
tissue specificity of AIDS-related syndromes.
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